BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 10358147)

  • 1. Diverse fine specificity and receptor repertoire of T cells reactive to the major VP1 epitope (VP1230-250) of Theiler's virus: V beta restriction correlates with T cell recognition of the c-terminal residue.
    Kim BS; Bahk YY; Kang HK; Yauch RL; Kang JA; Park MJ; Ponzio NM
    J Immunol; 1999 Jun; 162(12):7049-57. PubMed ID: 10358147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A predominant viral epitope recognized by T cells from the periphery and demyelinating lesions of SJL/J mice infected with Theiler's virus is located within VP1(233-244).
    Yauch RL; Kim BS
    J Immunol; 1994 Nov; 153(10):4508-19. PubMed ID: 7525707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. IV. Identification of an immunodominant T cell determinant on the N-terminal end of the VP2 capsid protein in susceptible SJL/J mice.
    Gerety SJ; Clatch RJ; Lipton HL; Goswami RG; Rundell MK; Miller SD
    J Immunol; 1991 Apr; 146(7):2401-8. PubMed ID: 1706400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope.
    Gerety SJ; Rundell MK; Dal Canto MC; Miller SD
    J Immunol; 1994 Jan; 152(2):919-29. PubMed ID: 7506740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. V. Mapping of a dominant immunopathologic VP2 T cell epitope in susceptible SJL/J mice.
    Gerety SJ; Karpus WJ; Cubbon AR; Goswami RG; Rundell MK; Peterson JD; Miller SD
    J Immunol; 1994 Jan; 152(2):908-18. PubMed ID: 7904291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A common TCR V-D-J sequence in V beta 13.1 T cells recognizing an immunodominant peptide of myelin basic protein in multiple sclerosis.
    Hong J; Zang YC; Tejada-Simon MV; Kozovska M; Li S; Singh RA; Yang D; Rivera VM; Killian JK; Zhang JZ
    J Immunol; 1999 Sep; 163(6):3530-8. PubMed ID: 10477628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microheterogeneity in the recognition of a HLA-DR2-restricted T cell epitope from a meningococcal outer membrane protein.
    Wiertz E; van Gaans-van den Brink J; Hoogerhout P; Poolman J
    Eur J Immunol; 1993 Jan; 23(1):232-9. PubMed ID: 7678224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of conserved T cell receptor CDR3 residues contacting known exposed peptide side chains from a major histocompatibility complex class I-bound determinant.
    Kelly JM; Sterry SJ; Cose S; Turner SJ; Fecondo J; Rodda S; Fink PJ; Carbone FR
    Eur J Immunol; 1993 Dec; 23(12):3318-26. PubMed ID: 8258346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric and functional analyses of central nervous system-infiltrating cells in SJL/J mice with Theiler's virus-induced demyelinating disease. Evidence for a CD4+ T cell-mediated pathology.
    Pope JG; Karpus WJ; VanderLugt C; Miller SD
    J Immunol; 1996 May; 156(10):4050-8. PubMed ID: 8621948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine specificity of the myelin-reactive T cell repertoire: implications for TCR antagonism in autoimmunity.
    Anderton SM; Manickasingham SP; Burkhart C; Luckcuck TA; Holland SJ; Lamont AG; Wraith DC
    J Immunol; 1998 Oct; 161(7):3357-64. PubMed ID: 9759852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CD4-mediated immune response is critical in determining the outcome of infection using Theiler's viruses with VP1 capsid protein point mutations.
    Rodriguez M; Roos RP; McGavern D; Zoecklein L; Pavelko K; Sang H; Lin X
    Virology; 2000 Sep; 275(1):9-19. PubMed ID: 11017783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The orientation and nature of the interaction between beef insulin-specific TCRs and the insulin/class II MHC complex.
    Wither JE; Vukusic B
    J Immunol; 1999 Feb; 162(4):2113-22. PubMed ID: 9973485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dramatic influence of V beta gene polymorphism on an antigen-specific CD8+ T cell response in vivo.
    Bour H; Michielin O; Bousso P; Cerottini JC; MacDonald HR
    J Immunol; 1999 Apr; 162(8):4647-56. PubMed ID: 10202004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunodominant framework region 3 peptide from TCR V beta 8.2 chain controls murine experimental autoimmune encephalomyelitis.
    Kumar V; Tabibiazar R; Geysen HM; Sercarz E
    J Immunol; 1995 Feb; 154(4):1941-50. PubMed ID: 7530748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the major histocompatibility complex loci and T-cell receptor beta-chain repertoire on Theiler's virus-induced demyelinating disease.
    Kim BS; Mohindru M; Kang B; Kang HS; Palma JP
    J Neurosci Res; 2005 Sep; 81(6):846-56. PubMed ID: 16049971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of both T cell receptor V alpha and V beta variable region domains and alpha chain junctional region in viral antigen recognition.
    Brändle D; Bürki K; Wallace VA; Rohrer UH; Mak TW; Malissen B; Hengartner H; Pircher H
    Eur J Immunol; 1991 Sep; 21(9):2195-202. PubMed ID: 1716213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: diverse V beta gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor V beta b and T cell receptor V beta a H-2b mice.
    Mendel Kerlero de Rosbo N; Ben-Nun A
    Eur J Immunol; 1996 Oct; 26(10):2470-9. PubMed ID: 8898962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural features of an antigen required for cellular interactions and for T cell activation in a MHC-restricted response.
    Langton BC; Mackewicz CE; Wan AM; Andria ML; Benjamini E
    J Immunol; 1988 Jul; 141(2):447-56. PubMed ID: 3260252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single amino acid replacements in an antigenic peptide are sufficient to alter the TCR V beta repertoire of the responding CD8+ cytotoxic lymphocyte population.
    Kalergis AM; Ono T; Wang F; DiLorenzo TP; Honda S; Nathenson SG
    J Immunol; 1999 Jun; 162(12):7263-70. PubMed ID: 10358174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of superantigen recognition by peptides of the variable region of the T cell receptor beta chain.
    MacNeil D; Fraga E; Singh B
    Eur J Immunol; 1992 Apr; 22(4):937-41. PubMed ID: 1532364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.